Illinois And Redwood City

Provides Promising Biologic Intended to Treat Multiple Sclerosis and Compounds that Complement Abbott's Existing Diverse Oncology Program

Older News

ABBOTT PARK, Illinois and REDWOOD CITY, California, March 9, 2010 - Abbott (NYSE: ABT) and Facet Biotech Corporation (Nasdaq: FACT) announced today a definitive agreement for Abbott to acquire Facet, enhancing Abbott's early- and mid-stage pharmaceutical pipeline.

MORE..

Corporate
|
Products
|
About Me
|
Contact
|
Privacy Policy